Commission Announces New Position to Lead Biodefense Policy and Research Efforts.
The Bipartisan Commission on Biodefense is seeking a Director of Policy and Research to develop and supervise the Commission’s biodefense policy and research agendas. The Commission, established in 2014, assesses the state of U.S. biodefense efforts and recommends changes to U.S. policy and law to strengthen national biodefense while optimizing resource investments. The Commissioners, all former high-ranking government officials, and the staff of four have conducted more than 20 public meetings and produced six reports, including the seminal A National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts. The pandemic of 2020 has shined a spotlight on the Commission’s work and this new Director of Policy and Research joins at an exciting time of high-intensity focus and rapid-growth. If you are interested, please send your resume to admin@biodefensecommission.org
News HighlightNew Commission Publication: Diagnostics For Biodefense – Flying Blind with No Plan to Land
In a new special focus report released today, Diagnostics for Biodefense – Flying Blind with No Plan to Land, the Bipartisan Commission on Biodefense provides an approach that would ensure the United States can rapidly develop innovative point-of-care and point-of-need diagnostic tests for COVID-19 and other novel, emerging, and reemerging infectious diseases when they occur.
More10 November, 2020
At this November 2020 meeting, the Commission assessed the national response to COVID-19 as those activities relate to the recommendations of the Blueprint. More details on this meeting can be found here.
Commission
December 10, 2020
The Best Books of 2020: Politics
Internecine conflicts within the executive branch are nothing new, as Tevi Troy shows in “Fight House: Rivalries in the White House From Truman to Trump”. But administrations have often needed more conflict, not less. Dr. Tevi Troy is an Ex Officio member of the Bipartisan Commission on Biodefense.
December 2, 2020
Former homeland security advisor plots response principles for crisis, emergency managers
Public trust must be maintained in preparing for and responding to another large-scale biological event like the ongoing novel coronavirus 2019 (COVID-19) pandemic, a former Trump administration emergency management expert told the Bipartisan Commission on Biodefense on Monday.
November 13, 2020
New report outlines diagnostic measures to control COVID-19
In a report released this week, “Diagnostics for Biodefense: Flying Blind with No Plan to Land,” the Bipartisan Commission on Biodefense describes the ways in which these missteps by the U.S. government lead to a public health breakdown. The report also outlines the diagnostics steps that should be taken to combat further spread of the virus.
November 12, 2020
Joe Lieberman, Tom Ridge: COVID-19 testing still isn’t adequate. We must invest more now.
So news that a vaccine has been shown to be 90% effective was really exciting. A safe, reliable vaccine is exactly what the world needs to turn the tide on this deadly virus. But vaccines are likely months away from large-scale manufacturing and wide distribution. In the meantime, it is crucial that the United States dramatically improves our ability to accurately diagnose COVID-19. We have a plan to do that.
November 10, 2020
New Commission Publication: Diagnostics For Biodefense – Flying Blind with No Plan to Land
In a new special focus report released today, Diagnostics for Biodefense – Flying Blind with No Plan to Land, the Bipartisan Commission on Biodefense provides an approach that would ensure the United States can rapidly develop innovative point-of-care and point-of-need diagnostic tests for COVID-19 and other novel, emerging, and reemerging infectious diseases when they occur.
